1. Ankjaer-Jensen A, Johnell O (1996) Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments. Osteoporos Int 6: 265–275.
2. Autier P, Haentjens P, Bentin J, et al. (2000) Costs induced by hip fractures: a prospective controlled study in Belgium. Osteoporos Int 11: 373–380.
3. Chrischilles E, Shireman T, Wallace R (1994) Costs and health effects of osteoporotic fractures. Bone 15: 377–386.
4. De Laet CEDH, van Hout BA, Burger H, Weel AEAM, Hofman A, Pols HAP (1999) Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam Study. Osteoporos Int 10: 66–72.
5. Eddy D, Johnston CC, Cummings SR, et al. (1998) Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int 8(supplement 4): 1–88.